Ali Alagheband is Co-Founder and Portfolio Manager of Sagard Healthcare Partners and joined the firm in 2019. Ali is responsible for overseeing Sagard’s healthcare strategy to invest in approved and commercialized biopharmaceuticals, diagnostics, and medical devices that are protected by strong intellectual property. Ali is a member of the Sagard Healthcare investment committee and is based in Toronto, Canada.
Prior to Sagard, Ali was a Managing Director and a member of the investment committee at DRI Capital, a healthcare royalty monetization firm in Toronto, Canada. Ali has over 20 years of healthcare investing experience focused on public equities and royalty-based opportunities.
Ali holds a B.A. in Physics (Honors) from Reed College, a B.Sc. in Engineering and Applied Science (Honors) from the California Institute of Technology, a M.Sc. in Mechanical Engineering from the Massachusetts Institute of Technology (MIT) and a Master in Business Administration from the University of Western Ontario, Richard Ivey School of Business.
